The influence of the needle length on long term glycaemic control in insulin using obese diabetic subjects
Recruiting
- Conditions
- 10012653diabetes (insulin administration)
- Registration Number
- NL-OMON31505
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 130
Inclusion Criteria
male and female adult patients diagnosed with Type 1 or Type 2 diabetes and using insulin for at least one year and have insulin injections with an insulin pen, have a BMI >= 30, have a skinfold thickness of > 10 mm at the injection sites, stable glycaemic control, hba1c between 6-10%, are capable of reading the written information and are prepared to, and capable of signing an informed consent.
Exclusion Criteria
patients who: change their own insulin dosage and are not prepared to keep an administration of these changes, are hypoglycaemia unaware, are pregnant or wish to become pregnant, have a BMI < 30, have a skinfold thickness of <= 10mm, have skin problems including lipodystrophy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>hypoglycemia, local complaints, and patients preference.</p><br>
- Secondary Outcome Measures
Name Time Method <p> HbA1c , fructosamine, serum 1,5-Anhydroglucitol</p><br>